HCSG vs. BIB
HCSG (Healthcare Services Group, Inc.) is a stock, while BIB (ProShares Ultra Nasdaq Biotechnology) is Leveraged Equities fund tracking the NASDAQ Biotechnology Index (200%). Over the past 10 years, HCSG returned -3.04%/yr vs 6.95%/yr for BIB. Their 0.37 correlation means their historical movements had little consistent relationship.
Performance
HCSG vs. BIB - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with HCSG having a 21.86% return and BIB slightly lower at 21.11%. Over the past 10 years, HCSG has underperformed BIB with an annualized return of -3.04%, while BIB has yielded a comparatively higher 6.95% annualized return.
HCSG
- 1D
- 0.95%
- 1M
- -7.36%
- 6M
- 23.80%
- YTD
- 21.86%
- 1Y
- 78.27%
- 3Y*
- 22.97%
- 5Y*
- -0.76%
- 10Y*
- -3.04%
- ALL TIME*
- 9.41%
BIB
- 1D
- -3.70%
- 1M
- -9.58%
- 6M
- 16.23%
- YTD
- 21.11%
- 1Y
- 90.29%
- 3Y*
- 23.98%
- 5Y*
- 0.36%
- 10Y*
- 6.95%
- ALL TIME*
- 17.28%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $704.96K | $1.10M | $967.78K | |
| $21.38M | $17.98M | $15.95M |
HCSG vs. BIB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HCSG Healthcare Services Group, Inc. | 21.86% | 64.61% | 12.01% | -13.58% | -28.66% | -34.56% | 19.52% | -37.76% | -22.39% | 36.77% |
BIB ProShares Ultra Nasdaq Biotechnology | 21.11% | 59.21% | -9.84% | -1.06% | -28.85% | -6.02% | 39.79% | 46.71% | -24.93% | 40.49% |
Correlation
The correlation between HCSG and BIB is 0.24, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.24 |
Correlation (3Y) Balances recent behavior with more history. | 0.39 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.37 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.34 |
Correlation (All Time) Calculated using the full available price history since Apr 8, 2010 | 0.37 |
The correlation between HCSG and BIB shifts across timeframes, from 0.24 (1 year) to 0.39 (3 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HCSG vs. BIB — Risk / Return Rank
HCSG
BIB
HCSG vs. BIB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Healthcare Services Group, Inc. (HCSG) and ProShares Ultra Nasdaq Biotechnology (BIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HCSG | BIB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.43 | ||
| Sortino ratioReturn per unit of downside risk | +0.02 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.34 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 4.00 | 5.48 | -1.49 |
| Martin ratioReturn relative to average drawdown | 11.35 | 15.43 | -4.09 |
Loading charts...
Drawdowns
HCSG vs. BIB - Drawdown Comparison
The maximum HCSG drawdown since its inception was -81.04%, which is greater than BIB's maximum drawdown of -67.24%. Use the drawdown chart below to compare losses from any high point for HCSG and BIB.
Loading charts...
Drawdown Indicators
| HCSG | BIB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.04% | -67.24% | -13.80% |
Max Drawdown (1Y)Largest decline over 1 year | -19.88% | -16.92% | -2.96% |
Max Drawdown (3Y)Largest decline over 3 years | -30.30% | -45.30% | +15.00% |
Max Drawdown (5Y)Largest decline over 5 years | -64.31% | -65.86% | +1.55% |
Max Drawdown (10Y)Largest decline over 10 years | -81.04% | -66.20% | -14.84% |
Current DrawdownCurrent decline from peak | -50.74% | -12.04% | -38.70% |
Average DrawdownAverage peak-to-trough decline | -32.07% | -32.55% | +0.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.99% | 6.00% | +0.99% |
Volatility
HCSG vs. BIB - Volatility Comparison
The current volatility for Healthcare Services Group, Inc. (HCSG) is 9.96%, while ProShares Ultra Nasdaq Biotechnology (BIB) has a volatility of 12.15%. This indicates that HCSG experiences smaller price fluctuations and is considered to be less risky than BIB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HCSG | BIB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.96% | 12.15% | -2.19% |
Volatility (6M)Calculated over the trailing 6-month period | 32.20% | 31.41% | +0.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.84% | 40.57% | +2.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 41.95% | 43.72% | -1.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.60% | 46.29% | -5.69% |
Dividends
HCSG vs. BIB - Dividend Comparison
HCSG has not paid dividends to shareholders, while BIB's dividend yield for the trailing twelve months is around 0.33%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 0.33% | 0.77% | 1.69% | 0.07% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
HCSG Healthcare Services Group, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 7.10% | 4.68% | 2.89% | 3.26% | 1.92% | 1.43% | 1.87% | 2.04% |
Frequently Asked Questions
HCSG and BIB have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIB has higher volatility (12.15%) compared to HCSG (9.96%). In terms of maximum drawdown, HCSG dropped -81.04% vs BIB's -67.24%.
BIB currently has the higher Sharpe Ratio (2.29 vs 1.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HCSG and BIB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer